The final label should reflect continuous capability
In a non-pregnant patient with type 2 diabetes, a GLP-1 agonist or SGLT2 inhibitor can be prescribed if adequate glycemic control is not achieved with metformin, sulphonylureas or (basal) insulin, or if weight reduction, hypoglycemia prevention or reduction of cardiovascular risk is the treatment goal (810)
Continuous dosing without a break blunts receptor sensitivity and reduces the efficacy of subsequent cycles
Go to treatments Best Sellers in Breeding supplements Coloring & Pigments Versele-Laga Can-Tax 150 g (Red Canary Feather Colourant )
Ajustes en el plan de tratamiento : Programe revisiones regulares con su equipo de atencin mdica, tpicamente cada 3-6 meses, para evaluar la respuesta al tratamiento, ajustar dosis de otros medicamentos (especialmente insulina o sulfonilureas para prevenir hipoglucemia), y monitorear parmetros como HbA1c, funcin renal y peso corporal